Am J Transplant, Volume 22, Suppl 3 Archives - Page 24 of 190 - ATC Abstracts

2022 American Transplant Congress
Accepting Rejection in Liver Transplant Recipients Requiring Renal Replacement Therapy: A Practice Paradigm
S. Farghaly¹, T. Sparkes¹, B. Masters¹, A. Haririan², N. Jakhete³, R. N. Barth⁴, D. Maluf⁵, S. Freedman¹
¹Pharmacy, University of Maryland Medical Center, Baltimore, MD, ²Nephrology, University of Maryland Medical Center, Baltimore, MD, ³Hepatology, University of Maryland Medical Center, Baltimore, MD, ⁴Transplant Surgery, University of Chicago Medical Center, Chicago, IL, ⁵Transplant Surgery, University of Maryland Medical Center, Baltimore, MD
*Purpose: The purpose of this study is to evaluate rejection outcomes in those requiring renal replacement therapy (RRT) after liver transplant.*Methods: This was a single…
2022 American Transplant Congress
Clinical Relevance of Class II HLA Mismatches in Living Donor Kidney Transplantation
J. Lan¹, M. Kadatz¹, D. Chang¹, R. Liwski², E. Wagner², P. Campbell², J. Gill¹, J. Gill¹
¹University of British Columbia, Vancouver, BC, Canada, ²On behalf of Canadian HLA Advisory Committee, Ottawa, ON, Canada
*Purpose: The benefit of class II HLA matching is primarily shown in deceased donor kidney transplantation. The objective of this study was to determine the…
2022 American Transplant Congress
Outcomes of Post-Operative Plasmapheresis in African American Kidney Transplant Recipients with High Panel Reactive Antibodies – A Single Center Experience
B. Valdepenas, M. Campara, J. Benken, C. Muran, D. Pierce, K. Heagler, P. DiCocco, J. Almario Alvarez, M. Spaggiari, I. Tang, I. Tzvetanov, E. Benedetti
University of Illinois at Chicago, Chicago, IL
*Purpose: African American (AA) kidney transplant (KTx) candidates are disadvantaged given increased immunologic risk and longer waitlist time. The purpose of this study was to…
2022 American Transplant Congress
Evaluation of Prophylactic Valganciclovir Dosing in Kidney Transplant Recipients at an Urban Transplant Institution
E. Foster¹, D. Pierce¹, T. Cairns¹, S. Borgetti², I. Tzvetanov³, E. Benedetti³, C. Muran¹
¹Pharmacy, University of Illinois at Chicago, Chicago, IL, ²Medicine, University of Illinois at Chicago, Chicago, IL, ³Surgery, University of Illinois at Chicago, Chicago, IL
*Purpose: Dosing and duration of cytomegalovirus (CMV) prophylaxis with valganciclovir (VGC) in kidney transplant (KT) recipients is variable by transplant center. Prior studies have shown…
2022 American Transplant Congress
Assessment of Pain Management Regimens After Living Donor Nephrectomy
M. Lebin¹, B. Crowther², K. Klingenberg², V. Lewis², K. Moller², H. Moore², K. Way², C. Lyda², A. Howell², R. Cooke³, P. Klem²
¹University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, ²University of Colorado Hospital, Aurora, CO, ³Boulder Community Hospital, Boulder, CO
*Purpose: Opioid sparing pain control protocols are widely accepted within health systems nationwide. In living donor kidney transplantation, pain control is addressed in a multimodal…
2022 American Transplant Congress
The Oncological Influences of Pre- and Post-Transplant Sustained Viral Response in Liver Transplant for Hepatocellular Carcinoma
K. Sasaki¹, S. Kimura², K. Tomiyama³, Y. Bekki⁴, M. Murray³, P. Huang³, M. Fruscione², A. Moro⁵, C. Kwon⁶
¹Stanford University, Stanford, CA, ²Massachusetts General Hospital, Boston, MA, ³University of Rochester, Rochester, NY, ⁴Mount Sinai Medical Center, New York, NY, ⁵University of South Florida, Tampa, FL, ⁶Cleveland Clinic, Cleveland, OH
*Purpose: Chronic hepatitis C infection (HCV) is one of the most common causes of hepatocellular carcinoma. After emerging direct-acting agents (DAA), the success rate of…
2022 American Transplant Congress
Increased Mortality After Kidney Transplantation in Mildly Frail Recipients: Need for Pretransplant Intervention
J. Pascual Santos¹, C. Arias-Cabrales¹, D. Redondo-Pachón¹, C. Burballa¹, A. Buxeda¹, A. Bach¹, A. Faura¹, E. Marco², L. Rodríguez-Mañas³, M. Crespo¹, M. J. Pérez-Sáez¹
¹Nephrology, Hospital del Mar, Barcelona, Spain, ²Rehabilitation, Hospital del Mar, Barcelona, Spain, ³Geriatrics, Hospital del Getafe, Getafe, Spain
*Purpose: Frailty is associated with a higher rate of complications and mortality after kidney transplantation (KT). Physical Frailty Phenotype (PFP) is the most used frailty…
2022 American Transplant Congress
An International Multi-Institutional Comparison of Liver Transplantation for Hepatocellular Carcinoma: United States, United Kingdom, and Canada
T. Ivanics¹, D. Wallace², M. P. Claasen³, M. Patel⁴, W. Jassem⁵, K. Menon⁵, A. Suddle⁵, N. Heaton⁵, N. Mehta⁶, J. van der Meulen², G. Sapisochin³
¹University of Toronto - University Health Network, Toronto, ON, Canada, ²Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom, ³Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada, ⁴Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, TX, ⁵Institute of Liver Studies, King's College Hospital, London, United Kingdom, ⁶UCSF, San Francisco, CA
*Purpose: Hepatocellular carcinoma (HCC) has become a leading indication for liver transplantation (LT) globally. Given the scarcity of organs, the general consensus has been that…
2022 American Transplant Congress
APN-Driven COVID-19 Monitoring Model for Kidney Transplant Patients
J. Yoo, S. Patel, T. Clevy-Schneller, A. Desai, R. Sodhi, D. Jain, S. Akkina
Loyola University Medical Center, Maywood, IL
*Purpose: COVID-19 infection in kidney transplant (KT) recipients is characterized by an unpredictable course and can be life-threatening. Prompt adjustment of immunosuppression and hospitalization when…
2022 American Transplant Congress
Performance of Aged Liver Grafts in a Rat Model of Normothermic Ex Vivo Liver Machine Perfusion
S. Moosburner¹, M. Zimmer¹, J. M. Gassner¹, N. Roschke¹, N. Berndt², J. Michelotto¹, K. H. Hillebrandt¹, J. Pratschke¹, I. M. Sauer¹, N. Raschzok¹
¹Department of Surgery, Experimental Surgery, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, ²Institute of Biochemistry, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
*Purpose: We aimed to characterize the performance of old vs. young liver grafts in a standardized rat model of normothermic ex vivo liver machine perfusion…